[go: up one dir, main page]

AU3665893A - Sequences characteristic of human gene transcription product - Google Patents

Sequences characteristic of human gene transcription product

Info

Publication number
AU3665893A
AU3665893A AU36658/93A AU3665893A AU3665893A AU 3665893 A AU3665893 A AU 3665893A AU 36658/93 A AU36658/93 A AU 36658/93A AU 3665893 A AU3665893 A AU 3665893A AU 3665893 A AU3665893 A AU 3665893A
Authority
AU
Australia
Prior art keywords
human gene
gene transcription
transcription product
sequences characteristic
sequences
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU36658/93A
Inventor
Mark D Adams
Ruben F Moreno
Craig J Venter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
United States Department of the Army
Government of the United States of America
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by United States Department of the Army, Government of the United States of America filed Critical United States Department of the Army
Publication of AU3665893A publication Critical patent/AU3665893A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1096Processes for the isolation, preparation or purification of DNA or RNA cDNA Synthesis; Subtracted cDNA library construction, e.g. RT, RT-PCR
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU36658/93A 1992-02-12 1993-02-12 Sequences characteristic of human gene transcription product Abandoned AU3665893A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83719592A 1992-02-12 1992-02-12
US837195 1992-02-12

Publications (1)

Publication Number Publication Date
AU3665893A true AU3665893A (en) 1993-09-03

Family

ID=25273788

Family Applications (1)

Application Number Title Priority Date Filing Date
AU36658/93A Abandoned AU3665893A (en) 1992-02-12 1993-02-12 Sequences characteristic of human gene transcription product

Country Status (2)

Country Link
AU (1) AU3665893A (en)
WO (1) WO1993016178A2 (en)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995014772A1 (en) * 1993-11-12 1995-06-01 Kenichi Matsubara Gene signature
WO1995018225A1 (en) 1993-12-24 1995-07-06 Medical Research Council Polycystic kidney disease 1 gene and uses thereof
US5605797A (en) * 1994-09-15 1997-02-25 Board Of Trustees Operating Michigan State University Bovine β-mannosidase gene and methods of use
US5863744A (en) * 1994-10-03 1999-01-26 New England Deaconess Hospital Corporation Neural cell protein marker RR/B and DNA encoding same
US7175995B1 (en) 1994-10-27 2007-02-13 Thomas Jefferson University TCL-1 protein and related methods
US5985598A (en) 1994-10-27 1999-11-16 Thomas Jefferson University TCL-1 gene and protein and related methods and compositions
US5985554A (en) * 1994-11-02 1999-11-16 Takeda Chemical Industries, Ltd. Method of probing the function of proteins or peptides encoded by partially sequenced cDNAs by inhibiting protein synthesis with antisense oligonucleotides
WO1997002280A1 (en) * 1995-06-30 1997-01-23 Human Genome Sciences, Inc. Breast specific genes and proteins
US5695937A (en) * 1995-09-12 1997-12-09 The Johns Hopkins University School Of Medicine Method for serial analysis of gene expression
US5866330A (en) 1995-09-12 1999-02-02 The Johns Hopkins University School Of Medicine Method for serial analysis of gene expression
AU4105396A (en) 1995-11-02 1997-05-29 Human Genome Sciences, Inc. Mammary transforming protein
US6509170B1 (en) 1996-03-14 2003-01-21 Human Genome Sciences, Inc. Polynucleotides encoding human tumor necrosis factor delta
US6541224B2 (en) 1996-03-14 2003-04-01 Human Genome Sciences, Inc. Tumor necrosis factor delta polypeptides
US7217788B2 (en) 1996-03-14 2007-05-15 Human Genome Sciences, Inc. Human tumor necrosis factor delta polypeptides
US6468766B1 (en) 1996-03-15 2002-10-22 President And Fellows Of Harvard College Aortic carboxypeptidase-like polypeptide
AU2996797A (en) * 1996-05-06 1997-11-26 Chiron Corporation Mammalian sex comb on midleg (mammalian (scm)) acts as an oncogene
WO1997042213A1 (en) * 1996-05-08 1997-11-13 Chiron Corporation MAMMALIAN ADDITIONAL SEX COMBS (MAMMALIAN Asx) ACTS AS AN ONCOGENE
IL127892A0 (en) * 1996-07-12 1999-10-28 Genentech Inc Gamma-heregulin
US5874285A (en) * 1996-09-13 1999-02-23 Incyte Pharmaceuticals, Inc. Polynucleotide encoding a novel human nm23-like protein
US5917028A (en) * 1996-10-29 1999-06-29 Incyte Pharmaceuticals, Inc. Human phosphoprotein
US5840559A (en) * 1996-10-30 1998-11-24 Incyte Pharmaceuticals, Inc. Human spermidine/spermine N1-acetyltransferase
US5889170A (en) * 1997-01-31 1999-03-30 Incyte Pharmaceuticals, Inc. Human integral membrane protein
US5939271A (en) * 1997-02-19 1999-08-17 The Regents Of The University Of California Netrin receptor
US5955312A (en) * 1997-02-24 1999-09-21 Incyte Pharmaceuticals, Inc. DNA encoding a novel microtubule-associated protein
AU6439598A (en) * 1997-02-26 1998-09-18 Genetics Institute Inc. Secreted proteins and polynucleotides encoding them
US6171787B1 (en) * 1997-06-26 2001-01-09 Abbott Laboratories Member of the TNF family useful for treatment and diagnosis of disease
US5948619A (en) * 1997-07-31 1999-09-07 Incyte Pharmaceuticals, Inc. Human zygin-1
EP1016718A1 (en) * 1997-08-13 2000-07-05 Chugai Research Institute for Molecular Medicine Inc. PROTEIN HAVING Zn FINGER-LIKE MOTIF
US6130068A (en) 1998-10-26 2000-10-10 Immunex Corporation Viral encoded semaphorin protein receptor DNA and polypeptides
CA2307014A1 (en) * 1997-10-28 1999-05-06 Immunex Corporation Viral encoded semaphorin protein receptor dna and polypeptides
US6562949B1 (en) 1997-10-28 2003-05-13 Immunex Corporation Antibodies to viral encoded semaphorin protein receptor polypeptides
US7214497B2 (en) 1997-10-28 2007-05-08 Immunex Corporation Viral encoded semaphorin protein receptor DNA and polypeptides
US6277565B1 (en) * 1997-11-06 2001-08-21 Millennium Pharmaceuticals, Inc. OCT-3 gene encoding transporter-like molecules
US5916753A (en) * 1997-11-13 1999-06-29 Incyte Pharmaceuticals, Inc. SH3-containing proteins
WO2000006708A1 (en) * 1998-07-29 2000-02-10 Kyowa Hakko Kogyo Co., Ltd. Novel polypeptide
AU767263B2 (en) 1998-10-09 2003-11-06 Genset Nucleic acids encoding human CIDE-B protein and polymorphic markers thereof
CA2347968A1 (en) * 1998-10-15 2000-04-20 Zymogenetics, Inc. Follistatin-related protein zfsta2
US6355788B1 (en) 1998-10-15 2002-03-12 Zymogenetics, Inc. Follistatin-related protein zfsta2
JP2002534961A (en) * 1998-12-18 2002-10-22 インサイト・ファーマスーティカルズ・インコーポレイテッド Lymphocyte membrane protein
IL132105A0 (en) * 1998-12-24 2001-03-19 Yeda Res & Dev Caspase-8 interacting proteins
GB9900167D0 (en) * 1999-01-06 1999-02-24 Univ Leeds Wound an tissue healing and orofacial clefting
DE19908423A1 (en) * 1999-02-26 2000-08-31 Deutsches Krebsforsch Protein involved in the development of the CNS
WO2000053734A2 (en) * 1999-03-09 2000-09-14 Schering Aktiengesellschaft Human angiogenesis relevant nucleic acid and protein sequences obtained from endothelial cells
US6558910B2 (en) 1999-09-10 2003-05-06 The Regents Of The University Of California SF, a novel family of taste receptors
MXPA02002538A (en) 1999-09-10 2005-07-01 Univ California T2r taste receptor family.
CA2387680A1 (en) 1999-10-22 2001-05-03 Wyeth Pablo, a polypeptide that interacts with bcl-xl, and uses related thereto
US20030153015A1 (en) * 2000-01-20 2003-08-14 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
WO2001055300A2 (en) * 2000-01-31 2001-08-02 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies
WO2001081361A1 (en) * 2000-04-11 2001-11-01 Cogent Neuroscience, Inc. Compositions and method for diagnosing and treating conditions, disorders, or diseases involving cell death
EP1209229A1 (en) * 2000-11-21 2002-05-29 Klaus-Peter Department of Psychiatry and Psychotherapy University of Würzburg Lesch Gene involved in schizophrenia
WO2002052005A1 (en) 2000-12-22 2002-07-04 Kazusa Dna Research Institute Foundation Novel genes and proteins encoded thereby
WO2002083921A2 (en) 2001-04-10 2002-10-24 Agensys, Inc. Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
US7927597B2 (en) 2001-04-10 2011-04-19 Agensys, Inc. Methods to inhibit cell growth
EP1401870A4 (en) 2001-05-24 2006-04-19 Human Genome Sciences Antibodies against tumor necrosis factor delta (april)
US20040081653A1 (en) 2002-08-16 2004-04-29 Raitano Arthur B. Nucleic acids and corresponding proteins entitled 251P5G2 useful in treatment and detection of cancer
CA2798390A1 (en) 2010-05-06 2011-11-10 Novartis Ag Compositions and methods of use for therapeutic low density lipoprotein - related protein 6 (lrp6) multivalent antibodies
EP2566892B1 (en) 2010-05-06 2017-12-20 Novartis AG Compositions and methods of use for therapeutic low density lipoprotein-related protein 6 (lrp6) antibodies
EP3252075A1 (en) 2011-11-04 2017-12-06 Novartis AG Low density lipoprotein-related protein 6 (lrp6) - half life extender constructs

Also Published As

Publication number Publication date
WO1993016178A2 (en) 1993-08-19
WO1993016178A3 (en) 1993-11-25

Similar Documents

Publication Publication Date Title
AU3665893A (en) Sequences characteristic of human gene transcription product
AU2240492A (en) Sequences characteristic of human gene transcription product
AU4106193A (en) Inflatable sheath for introduction of ultrasonic catheter
AU4277093A (en) Clad metallurgical products and methods of manufacture
AU6042396A (en) Amplification of nucleic acid sequences
AU6614696A (en) Inhibition of gene expression
AU5669494A (en) Human homolog of the e-cadherin gene and methods based thereon
AU1173195A (en) Treatment of immunoregulatory disorders
AU6614596A (en) Inhibition of gene expression
AU8153794A (en) Methods of inhibiting autoimmune diseases
AU6821994A (en) Electrode-carrying catheter and method of making same
AU6819194A (en) Isolated dna elements that direct pistil-specific and anther-specific gene expression and methods of using same
AU2861892A (en) Astrocyte-specific transcription of human genes
EP0731647A4 (en) Treatment of an edible product with humectants
AU7671394A (en) Expression control sequences of the p-selectin gene
AU3362293A (en) Control of gene transcription
AU6040296A (en) Methods of inducing bef-1 transcription factor
AU5845294A (en) Novel process and intermediates for the preparation of prodrugs
AU4641393A (en) Use of mtr gene sequences for expression of foreign genes
AU2548095A (en) Human inhibitor of apoptosis gene 1
AU672019B2 (en) Method of integrating gene into chromosome of (lactobacillus delbrueckii) species and product of gene integration
AU4489196A (en) Novel medical use of heme products
AU8007094A (en) High pressure treatment of food
AU7834994A (en) Therapeutic use of the retinoblastoma susceptibility gene product
AU4550089A (en) Ultraviolet stabilisation of acrylic polymers